Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The Nottingham prognostic index for invasive carcinoma of the breast.

Lee AH, Ellis IO.

Pathol Oncol Res. 2008 Jun;14(2):113-5. doi: 10.1007/s12253-008-9067-3. Epub 2008 Jun 10. Review.

PMID:
18543079
2.

[The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].

Jakić-Razumović J, Corić M, Vrbanec D, Babić D, Hlupić L, Belev B.

Lijec Vjesn. 2005 Jan-Feb;127(1-2):3-7. Croatian.

PMID:
16145866
3.

Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer.

Suen D, Chow LW.

Biomed Pharmacother. 2006 Jul;60(6):293-7. Epub 2006 Jun 27.

PMID:
16828252
4.

Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group.

Sundquist M, Thorstenson S, Brudin L, Nordenskjöld B.

Breast Cancer Res Treat. 1999 Jan;53(1):1-8.

PMID:
10206067
6.

Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.

Okugawa H, Yamamoto D, Uemura Y, Sakaida N, Yamada M, Tanaka K, Kamiyama Y.

Surg Today. 2005;35(11):907-11. Retraction in: Surg Today. 2009;39(8):738.

PMID:
16249842
7.

Future prospects for the staging of breast cancer.

Rutgers EJ, Peterse HL.

Semin Surg Oncol. 1996 Jan-Feb;12(1):3-11. Review.

PMID:
8821404
8.

[Prognostic and predictive factors of invasive breast cancer: update 2009].

Decker T, Hungermann D, Böcker W.

Pathologe. 2009 Feb;30(1):49-55. doi: 10.1007/s00292-008-1105-0. German.

PMID:
19184022
9.

Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.

Ahmad Z, Khurshid A, Qureshi A, Idress R, Asghar N, Kayani N.

Indian J Pathol Microbiol. 2009 Oct-Dec;52(4):477-81. doi: 10.4103/0377-4929.56123.

10.

A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.

Jézéquel P, Campone M, Roché H, Gouraud W, Charbonnel C, Ricolleau G, Magrangeas F, Minvielle S, Genève J, Martin AL, Bataille R, Campion L.

Breast Cancer Res Treat. 2009 Aug;116(3):509-20. doi: 10.1007/s10549-008-0250-8. Epub 2008 Nov 20.

PMID:
19020972
11.
12.

Prognostic factors in infiltrating lobular carcinoma.

Makhija PS, Rameshkumar K, Chinoy RF.

Indian J Pathol Microbiol. 2001 Jul;44(3):315-9.

13.

Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes.

Sidoni A, Bellezza G, Cavaliere A, Del Sordo R, Scheibel M, Bucciarelli E.

Breast. 2004 Feb;13(1):23-7.

PMID:
14759712
14.

A modified Nottingham prognostic index for breast cancer patients diagnosed in Denmark 1978-1994.

Rostgaard K, Mouridsen HT, Vaeth M, Holst H, Olesen KP, Lynge E.

Acta Oncol. 2001;40(7):838-43.

PMID:
11859983
15.

Prognostic factors in breast cancer: a brief review.

Fernö M.

Anticancer Res. 1998 May-Jun;18(3C):2167-71. Review.

PMID:
9703779
16.

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.

Blamey RW, Ellis IO, Pinder SE, Lee AH, Macmillan RD, Morgan DA, Robertson JF, Mitchell MJ, Ball GR, Haybittle JL, Elston CW.

Eur J Cancer. 2007 Jul;43(10):1548-55. Epub 2007 Feb 26.

PMID:
17321736
17.
18.

Classification and grading of invasive breast carcinoma.

Elston CW.

Verh Dtsch Ges Pathol. 2005;89:35-44.

PMID:
18035670
19.

The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker.

Cooke T, Reeves J, Lannigan A, Stanton P.

Eur J Cancer. 2001 Jan;37 Suppl 1:3-10.

PMID:
11342194
20.

Is hormone replacement therapy-related breast cancer more favorable? A case-control study.

Khan HN, Bendall S, Bates T.

Breast J. 2007 Sep-Oct;13(5):496-500.

PMID:
17760672

Supplemental Content

Support Center